Skip to content

INTS

Intensity Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$4.10
+2.50%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+7.4%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 20, 2026Donovan Daniel · directorA-Award5,500$4.90
Jul 20, 2026DUBIN THOMAS I H · directorA-Award5,500$4.90
Jul 20, 2026BENDER LEWIS H · director, officer: President and CEOA-Award78,000$4.90
Jul 20, 2026Talamo Joseph · officer: Chief Financial OfficerA-Award34,000$4.90
Jul 20, 2026Wesolowski John M · officer: Principal Accounting OfficerA-Award11,000$4.90
Jul 20, 2026Leahy Emer · directorA-Award5,500$4.90
Jul 20, 2026GOLDBERG MARK A · directorA-Award5,500$4.90
Jul 1, 2026Talamo Joseph · officer: Chief Financial OfficerA-Award1,093$3.48
Jul 1, 2026Wesolowski John M · officer: Principal Accounting OfficerA-Award3,688$3.48
Mar 30, 2026BENDER LEWIS H · director, officer: President and CEOA-Award37,749$6.11
Jan 5, 2026Wesolowski John M · officer: Principal Accounting OfficerA-Award8,918$0.26
Jan 5, 2026Talamo Joseph · officer: Chief Financial OfficerA-Award14,482$0.26
Jul 2, 2025Wesolowski John M · officer: Principal Accounting OfficerA-Award69,745$0.26
Jul 2, 2025Talamo Joseph · officer: Chief Financial OfficerA-Award14,179$0.26
May 6, 2025Donovan Daniel · directorA-Award50,000$0.57
May 6, 2025GOLDBERG MARK A · directorA-Award50,000$0.57
May 6, 2025Leahy Emer · directorA-Award50,000$0.57
May 6, 2025Wesolowski John M · officer: Principal Accounting OfficerA-Award100,000$0.57
May 6, 2025Talamo Joseph · officer: Chief Financial OfficerA-Award300,000$0.57
May 6, 2025BENDER LEWIS H · director, 10 percent owner, officer: President and CEOA-Award700,000$0.57
May 6, 2025DUBIN THOMAS I H · directorA-Award50,000$0.57
Oct 23, 2024Talamo Joseph · officer: Chief Financial OfficerA-Award427,379$3.44
Oct 23, 2024Wesolowski John M · officer: Principal Accounting OfficerA-Award70,028$3.44
Jun 7, 2024Wesolowski John M · officer: Principal Accounting OfficerM-Exempt1,000$4.00
May 15, 2024DUBIN THOMAS I H · directorA-Award50,000$4.42
Mar 7, 2024BENDER LEWIS H · director, 10 percent owner, officer: President and CEOA-Award464,805$5.19
Mar 7, 2024Donovan Daniel · directorA-Award50,000$5.19
Mar 7, 2024Leahy Emer · directorA-Award50,000$5.19
Mar 7, 2024Wesolowski John M · officer: See RemarksA-Award25,000$5.19
Mar 7, 2024GOLDBERG MARK A · directorA-Award50,000$5.19
Institutional positioning

13F filings over the trailing two quarters

New 5Increased 0Reduced 8Sold out 16
FilerActionSharesFiled
GEODE CAPITAL MANAGEMENT, LLCReduced26,019May 15, 2026
SAPIENT CAPITAL LLCReduced26,006Jun 22, 2026
NANO CAP NEW MILLENNIUM GROWTH FUND L PNew Position25,000May 15, 2026
SENTINUS, LLCReduced23,294May 6, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position16,841May 15, 2026
MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC.Reduced14,118Apr 21, 2026
VANGUARD FIDUCIARY TRUST CONew Position9,121May 8, 2026
NEWEDGE ADVISORS, LLCReduced1,148Jun 3, 2026
ADVISOR GROUP HOLDINGS, INC.New Position200May 15, 2026
WELLS FARGO & COMPANY/MNNew Position200Jul 8, 2026
UBS GROUP AGReduced192May 5, 2026
TOWER RESEARCH CAPITAL LLC (TRC)Reduced67May 15, 2026
MORGAN STANLEYReduced20May 15, 2026
UBS Group AGSold Out0May 5, 2026
OSAIC HOLDINGS, INC.Sold Out0May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 20, 2026